Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

1,002.97 805.60 813.56 831.81 728.29
Expenses

Material consumed

362.42 315.07 297.98 307.86 234.28

Manufacturing expenses

5.54 8.10 7.37 7.72 8.27

Personnel expenses

259.10 230.21 219.54 216.70 197.40

Selling expenses

- - - - -

Adminstrative expenses

210.79 166.04 153.20 178.83 217.04

Expenses capitalised

- - - - -

Cost of sales

837.85 719.42 678.09 711.11 656.99

Operating profit

165.12 86.18 135.47 120.70 71.30

Other recurring income

26.10 14.76 12.84 12.99 16.29

Adjusted PBDIT

191.22 100.94 148.31 133.69 87.59

Financial expenses

0.63 0.95 1.09 1.14 -

Depreciation

16.26 16.95 20.13 18.58 14.92

Other write offs

- - - - -

Adjusted PBT

174.33 83.04 127.09 113.97 72.67

Tax charges

34.81 21.44 33.79 41.76 18.22

Adjusted PAT

139.52 61.60 93.30 72.21 54.45

Non recurring items

-42.84 -1.74 3.43 -4.92 -0.60

Other non cash adjustments

- - - - -

Reported net profit

96.68 59.86 96.73 67.29 53.85

Earnigs before appropriation

475.64 383.96 329.10 235.38 168.22

Equity dividend

20.00 5.00 5.00 1.99 -

Preference dividend

- - - - -

Dividend tax

- - - 0.51 -

Retained earnings

455.64 378.96 324.10 232.88 168.22
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com